Intelligence · Patents
Patents expiring in 2034
Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.
- Patents
- 1,452
Quick answer
1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 8727775
Dimer acid-derived dimethacrylates and use in dental restorative compositions
granted -
US 8728524
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
granted -
US 8728493
Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs
granted -
US 8728526
Coacervate microparticles useful for the sustained release administration of therapeutic agents
granted -
US 8728532
Ischemia/reperfusion protection compositions and methods of using
granted -
US 8728447
Teeth-whitening gel
granted -
US 8728458
Combination anti-HIV vectors, targeting vectors, and methods of use
granted -
US 8729087
Compositions and methods for inhibition of the JAK pathway
granted -
US 8728757
Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
granted -
US 8729027
Therapeutic agent for fibromyalgia containing etanercept
granted -
US 8728488
Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
granted -
US 8729047
Compositions for inhibiting redox-sensitive GTPases
granted -
US 8729081
Compositions and methods for treating alcohol use disorders, pain and other diseases
granted -
US 8729053
Nuclear factor kappa B pathway inhibitor composition and use of same
granted -
US 8729100
Method and composition for treating an alpha adrenoceptor-mediated condition
granted -
US 8729115
Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
granted -
US 8729305
Process for the preparation of and crystalline forms of optical enantiomers of modafinil
granted -
US 8729102
Bicyclic compound
granted -
US 8728806
Methods and compositions related to Th-1 dendritic cells
granted -
US 8729119
Serotonin reuptake inhibitors
granted -
US 8729088
Toll-like receptor modulators and treatment of diseases
granted -
US 8729039
Use of inhibitory oligonucleotides to treat autoimmune disease
granted -
US 8728724
Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration
granted -
US 8728499
Dendritic macroporous hydrogels prepared by crystal templating
granted -
US 8728472
Antibodies that bind selectively to P25 and uses therefor
granted -
US 8729028
Noggin-derived peptide and use thereof
granted -
US 8729037
Method and medicament for inhibiting the expression of a given gene
granted -
US 8729248
Sperm-specific cation channel, CATSPER2, and uses therefor
granted -
US 2014142182
Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
granted -
CA 3169263
AGENTS DE TRAITEMENT DE MALADIES CANCEREUSES EXPRIMANT CLAUDINE
granted -
CA 2890920
DERIVES DE 1,3-DIHYDROIMIDAZOLE-2-THIONE UTILISABLES DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE PULMONAIRE ET DES LESIONS PULMONAIRES
granted -
US 8734786
Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
granted -
US 8734527
Encapsulated kidney tissue
granted -
US 8734429
Device, system and methods for the oral delivery of therapeutic compounds
granted -
US 8734808
Isolation of a virus related to canine parvovirus-2 from a raccoon
granted -
US 8734799
Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer
granted -
US 8735566
Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
granted -
US 8735360
Treatments for gastrointestinal disorders
granted -
US 8735414
Indole derivatives and methods for antiviral treatment
granted -
US 8735095
High affinity human antibodies to human IL-4 receptor
granted -
US 8735075
Cancer screening by detection of ultrastructural and molecular markers
granted -
US 8734830
Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
granted -
US 8734778
Yeast-based vaccines as immunotherapy
granted -
US 8734824
Hydrogel implants with varying degrees of crosslinking
granted -
US 8734825
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
granted -
US 8734853
HDL particles for delivery of nucleic acids
granted -
US 8734836
Methods and compositions for applying pharmacologic agents to the ear
granted -
US 8734930
Hydrogel implants with varying degrees of crosslinking
granted
Frequently asked questions
How many pharma patents expire in 2034?
1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.